Abstract: A battery system having a battery having at least one first battery element, at least one second battery element and a center tap between the at least one first and the at least one second battery element, a power changeover switch having a plurality of switching elements for changing over between the at least one first battery element and the at least one second battery element, and at least one pair of output terminals that is electrically connected to the battery, wherein the center tap has a first capacitive store arranged on it that has a store voltage that appears over an appropriate period in accordance with a first and/or second battery element voltage provided by the first and/or second battery element, wherein during the period in which the store voltage appears, a store current decreases from a maximum value to a value of zero.

Abstract: The present invention relates to a series of substituted compounds having the general formula (I), including their stereoisomers and/or their pharmaceutically acceptable salts. wherein R1, R2, R3, R4, R5, and R6 are as defined herein. This invention also relates to methods of making these compounds including intermediates. The compounds of this invention are effective at the kappa (?) opioid receptor (KOR) site. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic pain, and associated disorders, particularly functioning peripherally at the CNS.

Abstract: A vehicle component for a motor vehicle having a rear seat device with at least one headrest and having a wind deflector device with an extendable planar element for protecting front seats of the motor vehicle against relative wind. In an extended state, the planar element extends from a region behind the headrest to a region in front of the headrest. In this context, the headrest can be pivoted by a pivoting device from a position of use, in which the headrest projects beyond a height of the planar element in the extended state, into a position of rest. In the position of rest, the headrest is arranged under the extended planar element.

Abstract: An attachment device for a light strip on the tail or the nose of a motor vehicle is provided. The light strip is connected in a securely fixed manner at its free ends by attachment bolts. A further attachment bolt and a spring bias a central region of the light strip toward the vehicle, but permit limited movement of the light strip away from the vehicle in response to expansion of the light strip.

Abstract: An electrical energy store for a motor vehicle has multiple battery cells oriented in the same direction. Each battery cell has two parallel sides and a cell terminal with one plus pole and one minus pole. The battery cells are in the form of pouch cells between which there is arranged a cooling foil that comprises graphite particles and a cooling duct connected in heat-transmitting fashion to the cell terminal and to the foil.

Abstract: The invention pertains to a device for at least one low-frequency electric tank circuit, in which at least one electric conductor is an influencing component of the tank circuit due to its properties.

Abstract: An end plate for a rear spoiler of a vehicle, having a basic body with a fastening portion for fastening to an air directing wing of the rear spoiler. A first electric conducting body and, insulated electrically therefrom, a second electric conducting body are arranged at least in sections within the basic body. An electric light element which is electrically conductively connected to the two conducting bodies is furthermore arranged on the basic body.

Abstract: A modular system, including a plurality of modules that can be electrically connected to one another, wherein at least two first modules from amongst the modules can be connected to one another in series, wherein, in the connected state of the first modules, a first contact-making means is arranged between the first modules, wherein a second of the modules has a second contact-making means, wherein the first contact-making means and the second contact-making means are configured to make electrical contact with one another, wherein the first contact-making means and the second contact-making means are configured, when making electrical contact with one another, firstly to connect the first modules to the second module and then to isolate the connection of the first modules to one another.

Abstract: The disclosure is directed towards a highly emollient, plant-based moisturizer which noticeably reduces the visible signs of aging and effects of environmental impact. With one daily application, the formula reaches deep into the cellular structures to hydrate skin, delivering a luminous, porcelain effect on all skin types and ages. In an embodiment, the emulsion is provided in the form of a skin cream effective for reducing the visible signs of aging and effects of environmental impact. The skin cream formulation includes a mixture of at least one member of the genus of flowering plants known as Convallaria, an amphiphilic material, such as lecithin, Centella (Centella asiatica or C. Asiatica), an essential oil such as Myrrh; a product derived from aloe, a whole or reconstituted milk formulation, and a mineral clay, in amounts effective to reduce such signs of aging and environmental impact.

Abstract: In a device and a method for the automated detection of an interface between a position-measuring device and sequential electronics that are interconnected via a data-transmission channel, the position-measuring device includes an interface unit and a position-measuring unit. The interface unit is connected first of all to the data-transmission channel, and secondly to the position-measuring unit for the purpose of an internal data exchange. The interface to the sequential electronics is selectable in the interface unit from at least two interfaces.

Abstract: An optical position-measuring device includes a scale and a scanning reticle, whose relative position is determinable in three linearly independent spatial directions using interfering light beams. A splitter grating is disposed on the scanning reticle and adapted to split light into sub-beams of different diffraction orders. An optical grating is disposed on the scale and adapted to further split the sub-beams and to recombine them after they have been reflected back from the scanning reticle. Grating fields configured as phase gratings are disposed on a side of the scanning reticle that faces the scale. The grating fields act as diffractive optics that influence the further split sub-beams. The grating fields have different step heights. An output grating is disposed on the scanning reticle and adapted to output, as interfering sub-beams, light that has been multiply reflected between the scale and the scanning reticle.

Abstract: A temperature-control arrangement has an electrical energy store, a thermal device, a cooling device and a coolant circuit with coolant lines, which coolant lines are at least partially activatable and deactivatable by means of controllable valves. The temperature-control arrangement is designed to permit at least a first state and a second state of the coolant circuit through actuation of the controllable valves, wherein the coolant circuit is designed to, in the first state, permit a coolant flow from the cooling device both to the thermal device and to the electrical energy store, and from these back to the cooling device, in order to cool the thermal device and the electrical energy store, and wherein the coolant circuit is designed to, in the second state, permit a coolant flow from the thermal device to the electrical energy store, and from the latter back to the thermal device, in order to heat the electrical energy store.

Abstract: The present invention relates to substituted morpholine derivatives having pharmacological activity towards the sigma (?) receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.

Abstract: A plasticizing unit of an injection molding machine for micro-injection molding includes a plasticizing cylinder and a screw, which conveys material to be plasticized from a feed opening in the direction of an outlet opening. At least one longitudinal section of the plasticizing cylinder between the feed opening and the outlet opening is formed as a transition region in which the inner diameter of the plasticizing cylinder tapers in the direction of the outlet opening to the outer diameter of the screw. The transition region is formed by a sleeve-shaped transition element which is removably and replaceably mounted within the plasticizing cylinder. The plasticizing cylinder is designed as at least two parts for removing and replacing the sleeve-shaped transition element.

Abstract: A drive arrangement for auxiliary units in a motor vehicle has a control unit and an electric drive unit that is connected via a transmission arrangement to at least one auxiliary unit. An electric drive unit (8) is connected in terms of drive to at least two auxiliary units (4, 6) by drive trains (12, 16) of a transmission arrangement (10). Clutch members (22, 24) for coupling or decoupling the auxiliary units (4, 6) in terms of drive are provided in the respective drive trains (12, 14).

Abstract: The present invention relates, e.g., to a method for inducing arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or for inducing mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte, comprising administering to a cell or tissue in need thereof a dose of a polynucleotide that encodes a vascular endothelial growth factor (VEGF), or that encodes a polypeptide comprising an active site of the VEGF. The coding sequence is operably linked to an expression control sequence; and the dose is sufficient to induce arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or to induce mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte. In preferred embodiments of the invention, the method is a method of tissue regeneration, particularly of cardiomyogenesis; and the polynucleotide (or a polypeptide encoded by such a polynucleotide) is administered into the myocardium.

Abstract: An on-board charger for an electrically driven vehicle having (i) at least one connector for connecting a plug, the connector including a seal for sealing the connector; and (ii) an edge, running around the connector, for protecting the seal against sprayed water. A method for manufacturing the on-board charger includes the steps of injection molding a housing of the on-board charger, and integrally injection molding the edge onto the housing. A vehicle includes a drive which is supplied with electrical driving energy, a traction battery for storing the driving energy, and the on-board charger for charging the traction battery with the driving energy.

Abstract: A charging apparatus (22) for a motor vehicle (10) has a plurality of plug connection members (12, 14, 16) to connect the charging apparatus (22) to at least one external electrical energy source (18, 20), a plurality of temperature measuring elements (26, 28, 30) are associated respectively with the plug connection members (12, 14, 16) to detect a temperature of the plug connection members (12, 14, 16), and an evaluation unit (32) electrically connected to the temperature measuring elements (26, 28, 30) to evaluate the detected temperature of the temperature measuring elements (26, 28, 30). The temperature measuring elements (26, 28, 30) are connected to the evaluation unit (32) by a common first connecting line (42), and connectable electrically to the control unit (32) individually by a second connecting line (36, 38, 40) in each case.

Abstract: An assay method for the detection of potential for CVD or propensity to CVD in a human or non-human animal subject, said method comprising assessing the concentration of calprotectin in a calprotectin-containing sample taken from said subject.